BSE · SHREEGANES
Shree Ganesh Biotech (India) Limited (SHREEGANES) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,218
of 5,047 stocks
▲ 201W▼ 411M
Peak #4,104 · 02 Oct 2026
A microcap name in Healthcare, Shree Ganesh Biotech (India) Limited carries a steep earnings multiple that prices in strong future growth, is seeing revenue contract sharply, and has a subdued return on equity.
Market Cap
17.94 Cr
P/E Ratio
45.00
P/B Ratio
0.28
ROE
0.59%
ROCE
0.81%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 16.00 L | 1.43 Cr | 2.12 Cr | 69.81 L |
| Net Profit | -8.09 L | -57.33 L | -14.92 L | 32.22 L |
| EPS | 0.00 | 0.01 | 0.00 | 0.01 |
| Operating Profit | -8.09 L | -57.33 L | -14.92 L | 32.22 L |
Shareholding pattern
Promoter
0.00%
Public
100.00%
PUBLIC BREAKDOWN
FII
1.42%
Individuals
97.05%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 27 Apr 2022 | Bonus | Bonus issue 1:1 |
| 10 Feb 2022 | Split | Stock Split From Rs.10/- to Rs.1/- |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.